DOES ADDING CONCOMITANT IMMUNOSUPPRESSIVE THERAPY TO BELIMUMAB PROVIDE ADDITIONAL BENEFITS IN SLE? ANALYSIS FROM BEL-SPAIN: THE SPANISH BELIMUMAB MULTICENTER REGISTRY | Publicación